Literature DB >> 15689221

Purpuric drug eruption possibly due to gefinitib (Iressa).

Ichiro Kurokawa, Kazuo Endo, Masataka Hirabayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15689221     DOI： 10.1111/j.1365-4632.2005.02185.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

1.  Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.

Authors:  Anna Ferrazzi; Irene Russo; Giulia Pasello; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2015-11-19       Impact factor: 2.447

Review 2.  Cutaneous complications of molecular targeted therapy used in oncology.

Authors:  I Lupu; N Voiculescu; N Bacalbasa; I Cojocaru; V Vrancian; C Giurcaneanu
Journal:  J Med Life       Date:  2016 Jan-Mar

3.  Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein.

Authors:  Tamio Okimoto; Yukari Tsubata; Takamasa Hotta; Megumi Hamaguchi; Takae Okuno; Yohei Shiratsuki; Akari Kodama; Mika Nakao; Yoshihiro Amano; Shunichi Hamaguchi; Noriaki Kurimoto; Reiko Tobita; Takeshi Isobe
Journal:  Oncotarget       Date:  2018-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.